Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F22%3A10452406" target="_blank" >RIV/00669806:_____/22:10452406 - isvavai.cz</a>

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TZ673EW5xU" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TZ673EW5xU</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/jcm11247354" target="_blank" >10.3390/jcm11247354</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies

Popis výsledku v původním jazyce

Hematological malignancies are considered to be one of the most important causes of mortality and morbidity in the modern world. Still, important progress has been made in the last decade due to breakthroughs in hematopoietic stem cell transplantation and cellular therapies. The results of these recent studies show that a promising road toward state-of-the-art treatment for the hematology patient, turning the diagnosis of leukemia or lymphoma into a curable disease, has already begun, with recent advances in hematopoietic stem cell transplantation and immunotherapy, and is now progressing forward. The prospect of providing a definitive alternative therapy for various malignancies, rather than conventional chemotherapy management, is indeed clinically, socially, and economically attractive, due to the huge medical, social, and economic burden that a malignancy imposes.

Název v anglickém jazyce

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies

Popis výsledku anglicky

Hematological malignancies are considered to be one of the most important causes of mortality and morbidity in the modern world. Still, important progress has been made in the last decade due to breakthroughs in hematopoietic stem cell transplantation and cellular therapies. The results of these recent studies show that a promising road toward state-of-the-art treatment for the hematology patient, turning the diagnosis of leukemia or lymphoma into a curable disease, has already begun, with recent advances in hematopoietic stem cell transplantation and immunotherapy, and is now progressing forward. The prospect of providing a definitive alternative therapy for various malignancies, rather than conventional chemotherapy management, is indeed clinically, socially, and economically attractive, due to the huge medical, social, and economic burden that a malignancy imposes.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30205 - Hematology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů